Shijiazhuang Xindong Technology Service
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shijiazhuang Xindong Technology Service between 21 Aug 2025 and 5 May 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Shijiazhuang Xindong Technology Service
Retatrutide
Tested 4 Samples
Last test 5 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Shijiazhuang Xindong Technology Service
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
5 May 2026
First
21 Aug 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 5 May 2026 | View | 30mg | 26.9mg | -10.3% | 99.90% | below LOQ | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 3 Mar 2026 | View | 10mg | 9.94mg | -0.6% | 99.90% | n/a | (no batch ID) | (no data) | Lab E | Public | |
| 21 Aug 2025 | View | 10mg | 9.61mg | -3.9% | 99.94% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 21 Aug 2025 | View | 10mg | 10.3mg | +3.0% | 99.89% | n/a | XR23110301-2 | No Label / Blue Crimp / Clear Cap | Lab E | Public | |